Crossmark

Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease

Crossref DOI link: https://doi.org/10.1016/j.medcle.2022.05.028

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pampín-Sánchez, Rubén

Martínez-Mugica-Barbosa, Cristina

Fonseca-Aizpuru, Eva María

Barbazán-Vázquez, Francisco Javier

Fernández-González, Beatriz

Buznego-Súárez, Loreto
License Information

Text and Data Mining valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2022.05.028

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.